STAAR Surgical Cost of Goods Sold 2010-2024 | STAA
STAAR Surgical cost of goods sold from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
STAAR Surgical Annual Cost of Goods Sold
(Millions of US $) |
| 2023 |
$70 |
| 2022 |
$61 |
| 2021 |
$52 |
| 2020 |
$45 |
| 2019 |
$38 |
| 2018 |
$32 |
| 2017 |
$26 |
| 2016 |
$24 |
| 2015 |
$24 |
| 2014 |
$26 |
| 2013 |
$22 |
| 2012 |
$19 |
| 2011 |
$20 |
| 2010 |
$20 |
| 2009 |
$20 |
STAAR Surgical Quarterly Cost of Goods Sold
(Millions of US $) |
| 2024-09-30 |
$20 |
| 2024-06-30 |
$21 |
| 2024-03-31 |
$16 |
| 2023-12-31 |
$16 |
| 2023-09-30 |
$17 |
| 2023-06-30 |
$22 |
| 2023-03-31 |
$16 |
| 2022-12-31 |
$14 |
| 2022-09-30 |
$16 |
| 2022-06-30 |
$17 |
| 2022-03-31 |
$14 |
| 2021-12-31 |
$14 |
| 2021-09-30 |
$13 |
| 2021-06-30 |
$13 |
| 2021-03-31 |
$12 |
| 2020-12-31 |
$12 |
| 2020-09-30 |
$12 |
| 2020-06-30 |
$11 |
| 2020-03-31 |
$10 |
| 2019-12-31 |
$10 |
| 2019-09-30 |
$10 |
| 2019-06-30 |
$10 |
| 2019-03-31 |
$8 |
| 2018-12-31 |
$8 |
| 2018-09-30 |
$8 |
| 2018-06-30 |
$9 |
| 2018-03-31 |
$8 |
| 2017-12-31 |
$7 |
| 2017-09-30 |
$7 |
| 2017-06-30 |
$6 |
| 2017-03-31 |
$6 |
| 2016-12-31 |
$6 |
| 2016-09-30 |
$5 |
| 2016-06-30 |
$6 |
| 2016-03-31 |
$6 |
| 2015-12-31 |
$6 |
| 2015-09-30 |
$6 |
| 2015-06-30 |
$6 |
| 2015-03-31 |
$6 |
| 2014-12-31 |
$7 |
| 2014-09-30 |
$6 |
| 2014-06-30 |
$6 |
| 2014-03-31 |
$6 |
| 2013-12-31 |
$6 |
| 2013-09-30 |
$5 |
| 2013-06-30 |
$6 |
| 2013-03-31 |
$5 |
| 2012-12-31 |
$5 |
| 2012-09-30 |
$5 |
| 2012-06-30 |
$5 |
| 2012-03-31 |
$5 |
| 2011-12-31 |
$5 |
| 2011-09-30 |
$5 |
| 2011-06-30 |
$5 |
| 2011-03-31 |
$5 |
| 2010-12-31 |
$5 |
| 2010-09-30 |
$5 |
| 2010-06-30 |
$5 |
| 2010-03-31 |
$5 |
| 2009-12-31 |
$5 |
| 2009-09-30 |
$5 |
| 2009-06-30 |
$5 |
| 2009-03-31 |
$5 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$1.288B |
$0.322B |
|
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
|
